ArticleFEBS open bio2026
HSP70 governs permeability and mechanotransduction in primary human endothelial cells.
Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Recent insights into HSP70: proteostasis and beyond.Frontiers in molecular biosciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Vascular barrier disruption is a hallmark of diseases such as cardiovascular disease, stroke, hypertension, pulmonary disorders, infections, and cancer. Endothelium permeability is tightly regulated by shear stress, allowing tissue perfusion, while disturbed flow leads to increased permeability. Cell-cell junctional proteins, including platelet/endothelial cell adhesion molecule-1 (PECAM-1)/CD31 and VE-cadherin, play significant roles in mechanotransduction and barrier integrity. The 70 kDa heat shock protein HSP70 has a well-established cytoprotective function in cardiovascular physiology. Here, we hypothesized that HSP70 interacts with and regulates these junctional proteins. We found that PECAM-1 and VE-cadherin co-immunoprecipitate with endogenous HSP70, and both proteins exhibited positive proximity ligation assay signals in the endothelial monolayers. HSP70 loss of function leads to disassembly of VE-cadherin and PECAM-1 at the cell surface and selectively decreases PECAM-1 steady-state expression. Consistent with its vascular protective role, HSP70 inhibition also reduced endothelial nitric oxide synthase (eNOS) levels. Furthermore, HSP70 was essential for maintaining normal paracellular flux in primary vein (HUVEC) and coronary artery endothelial cells (HCAEC) monolayers, as well as for promoting natural cell alignment under physiological laminar shear stress in HUVEC. These results demonstrate that HSP70 regulates the quality control of interendothelial adherens junctions, mediates responses to hemodynamic forces, and maintains monolayer barrier function across vascular beds. Our findings advance the mechanistic understanding of how human HSP70 mediates vascular homeostasis through endothelium responses to blood flow and permeability in addition to HSP70 role in migration, proliferation, and angiogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.